Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

NCT03867136 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

354

Enrollment

OTHER

Sponsor class

Conditions

Multidrug Resistant Tuberculosis

Interventions

DRUG: PZA sensitivity guided ultra-short all Oral Regimen
DRUG: Standardized Shorter Regimen

Sponsor

Huashan Hospital